12 employees
Resilient Biotics utilizes big data analytics to design microbiome-based therapeutics and advanced screening methods.
2016
$7.2M
from 4 investors over 4 rounds
Resilient Biotics raised $7.2M on January 29, 2021
Investors: Fulcrum Global Capital, Viking Global Investors, Elanco and Berkeley Catalyst Fund